Patent · US Active

Compositions and methods for treating or preventing prostate cancer and for detecting androgen receptor variants

US9146238B2 · kind B2 · utility

6Cited by
0References
3Claims
0Family size

Assignee

Inventors

Key dates

Filing dateApr 16, 2009
Grant dateSep 29, 2015
Priority date
Expiry dateMay 27, 2030

Classification

  • Technology area (CPC G)Physics
  • CPC primaryG01N2800/56
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The invention features diagnostic and therapeutic methods and compositions featuring androgen receptor variant proteins and nucleic acid molecules whose expression is increased in androgen related diseases or disorders.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.